科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 查找姓氏以该字母开头的医生 A
  2. 主动 查找姓氏以该字母开头的医生 B
  3. 查找姓氏以该字母开头的医生 C
  4. 查找姓氏以该字母开头的医生 D
  5. 查找姓氏以该字母开头的医生 E
  6. 未找到姓氏以该字母开头的医生 F
  7. 查找姓氏以该字母开头的医生 G
  8. 未找到姓氏以该字母开头的医生 H
  9. 未找到姓氏以该字母开头的医生 I
  10. 未找到姓氏以该字母开头的医生 J
  11. 未找到姓氏以该字母开头的医生 K
  12. 未找到姓氏以该字母开头的医生 L
  13. 未找到姓氏以该字母开头的医生 M
  14. 未找到姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 查找姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 查找姓氏以该字母开头的医生 R
  19. 查找姓氏以该字母开头的医生 S
  20. 未找到姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 未找到姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: B

  1. Gabor Bagameri, M.D.

    Gabor Bagameri, M.D.

    1. Cardiovascular Surgeon
    1. Rochester, MN
    擅长领域:

    Aortic arch replacement, Heart valve surgery, Pericardiectomy, Mitral valve repair and replacement, Aortic valve repair... and replacement, Minimally invasive heart surgery, Septal myectomy, Endovascular treatment, Vascular stenting, Coronary bypass surgery, Transcatheter aortic valve replacement, Valve-sparing aortic root replacement, Tricuspid valve repair and replacement, Pulmonary valve repair and replacement, Aortic root surgery, Hypertrophic cardiomyopathy, Tricuspid valve disease

研究

妙佑医疗国际的医生和研究人员持续开展心血管研究工作,经导管主动脉瓣置换术(TAVR)便是其中之一。研究人员专注于通过改进技术减少并发症以及更加透彻地了解哪些患者最适合 TAVR

妙佑医疗的医生撰写或与他人合写了大量 TAVR 相关文章,并参加了许多研究。研究 TAVR 长期结局的研究人员发现,TAVR 的死亡率与瓣膜置换术相似。详细了解心血管研究中心开展的研究。

文献

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在经导管主动脉瓣置换术(TAVR)领域的文献目录

Research Profiles

查看所有医生 • Florida

在 Mayo Clinic 治疗

Oct. 13, 2021
  1. Gaasch WH, et al. Indications for valve replacement in aortic stenosis in adults. https://www.uptodate.com/contents/search. Accessed Aug. 3, 2021.
  2. What is heart valve disease? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/hvd. Accessed Aug. 3, 2021.
  3. What is TAVR? (TAVI). American Heart Association. https://www.heart.org/en/health-topics/heart-valve-problems-and-disease/understanding-your-heart-valve-treatment-options/what-is-tavr. Accessed Aug. 3, 2021.
  4. AskMayoExpert. Aortic stenosis (adult). Mayo Clinic; 2018.
  5. Otto CM, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2021; doi:10.1016/j.jacc.2020.11.018.
  6. Otto CM, et al. Medical management of symptomatic aortic stenosis. https://www.uptodate.com/contents/search. Accessed Aug. 3, 2021.
  7. Cormican D, et al. TAVR procedural volumes and patient outcomes: Analysis of recent data. Journal of Cardiothoracic and Vascular Anesthesia. 2020; doi:10.1053/j.jvca.2019.04.016.
  8. Dalby M, et al. Transcatheter aortic valve replacement: Complications. https://www.uptodate.com/contents/search. Accessed Aug. 3, 2021.
  9. Kolte D, et al. Outcomes following urgent/emergent transcatheter aortic valve replacement: Insights from the STS/ACC TVT registry. JACC: Cardiovascular Interventions. 2018; doi:10.1016/j.jcin.2018.03.002.
  10. Office of Patient Education. Transcatheter aortic valve replacement. Mayo Clinic; 2019.
  11. Phillips SD (expert opinion). Mayo Clinic. March 9, 2020.
  12. Arora S, et al. Transcatheter aortic valve replacement: Comprehensive review and present status. Texas Heart Institute Journal. 2017; doi:10.14503/THIJ-16-5852.
  13. Gleason TG, et al. 5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. Journal of the American College of Cardiology. 2018; doi:10.1016/j.jacc.2018.08.2146.
  14. Braswell Pickering EA. Allscripts EPSi. Mayo Clinic. July 6, 2021.
  15. Brecker SJD, et al. Transcatheter aortic valve replacement: Periprocedural and postprocedural management. https://www.uptodate.com/contents/search. Accessed Aug. 3, 2021.
  16. Reardon MJ, et al. Outcomes in the randomized CoreValve US pivotal high-risk trial in patients with a Society of Thoracic Surgeons risk score of 7% or less. JAMA Cardiology 2016; doi:10.1001/jamacardio.2016.2257.
  17. Makkar RR, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. New England Journal of Medicine. 2020; doi:10.1056/NEJMoa1910555.

经导管主动脉瓣置换术 (TAVR)